GRP and head and neck squamous cell carcinoma: In HNSCC, stimulation of GRPR by its ligand GRP promotes dose-dependent proliferation and MAPK activation, whereas disruption of the GRP-GRPR axis inhibits cell growth in vitro and in vivo, consistent with an autocrine regulatory pathway and suggesting that increased GRPR expression may be an early event in HNSCC development18,28.